Scientific Advisory Board
Friends of FSH Research manages a portfolio of grants to accelerate discoveries for FSHD. To do this, we leverage the expertise of our world-class scientific advisory board.
Our Board members are bound by a set of Covenants. Please do not hesitate to contact us to learn more about how we review our science, and maintain an active an collaborative culture to ensure robust and reproducible findings.
Dr. Block is VP Corporate Development at Universal Cells, and Director of Business Development, Regenerative Medicine, at Astellas Pharmaceuticals.
Dr. Chamberlain is a Professor of Neurogenetics, Biochemistry, and Medical Genetics, University of Washington. He also chairs our Scientific Advisory Board.
Dr. Premi Haynes is a Senior Scientist at Bristol Myers Squibb located in Seattle, WA.
Dr. Kennedy is Director, Centre for Healthy Longevity and Professor Departments of Biochemistry and Physiology at National University of Singapore.
Dr. Van der Maarel is a Professor of Medical Epigenetics at Leiden University Medical Center in The Netherlands.
Amanda Rickard is a scientist in Epigenetics at Pfizer Oncology in San Diego and Friends of FSH Research Board of Directors member.
Dr. Shaw is Division Chief of MRI and Vascular/Interventional Imaging at Seattle Children's Hospital.
Dr. Tawil is the Director of the Neuromuscular Pathology Laboratory at the University of Rochester.
Dr. Wentworth is the Senior Scientific Advisor at Dyne Therapeutics.
Dr. Yokomori is a Professor, Biological Chemistry School of Medicine, University of California at Irvine.
Connect with us on social media